Nilanjan Ghosh, MD, PhD, on Real-World Efficacy of CAR T-Cell Therapies

The chief of the lymphoma division and oncologist at Levine Cancer Institute discussed data from real-world experience studies.

Liso-Cel Approved for Second-Line Large B-Cell Lymphoma

The approval builds off of liso-cel's (Breyanzi) previous indication for third-line or later treatment in LBCL.

CGTLive’s Weekly Rewind – June 24, 2022

Review top news and interview highlights from the week ending June 24, 2022.

Val-Rox Approval Favored in Europe, Stalled in US

BioMarin received a positive CHMP opinion after the FDA delayed val-rox's BLA filing for the second time.

Krystal Seeks Approval for Dystrophic Epidermolysis Bullosa Gene Therapy

B-VEC recently showed efficacy in the phase 3 GEM-3 trial.

Steven W. Pipe, MD, on Challenges in Gene Therapy Trials for Hemophilia

The director of the Pediatric Hemophilia and Coagulation Disorders Program at CS Mott Children’s Hospital discussed common challenges with gene therapy clinical trials.